Related Experiment Video
Updated: May 28, 2026
05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
Evolution of lipid profiles after bariatric surgery
Ignacio Garcia-Marirrodriga1, Cesar Amaya-Romero, Gabriel Patiño Ruiz-Diaz
1Centro Laparoscópico Dr. Ballesta (CLB), Centro Médico Teknon, 08022, Barcelona, Spain.
Obesity Surgery
|November 1, 2011
Summary
Laparoscopic Roux-en-Y gastric bypass (LRYGBP) significantly improves lipid profiles and reduces insulin resistance in obese patients. This weight loss surgery leads to lower cholesterol and triglycerides, and higher HDL cholesterol, with males showing greater improvements.
Area of Science:
- Metabolic Surgery
- Bariatric Procedures
- Cardiovascular Health
Background:
- Obesity is frequently associated with dyslipidemia, including hypertriglyceridemia, low HDL cholesterol, and elevated small, dense LDL cholesterol.
- These lipid abnormalities contribute to increased cardiovascular risk in obese individuals.
Purpose of the Study:
- To evaluate the impact of laparoscopic Roux-en-Y gastric bypass (LRYGBP) on lipid profiles.
- To assess changes in lipid sub-fractions and insulin resistance at 6, 12, and 18 months post-surgery.
Main Methods:
- Retrospective observational study of 114 patients undergoing LRYGBP.
- Measurement of fasting lipid sub-fractions (total cholesterol, LDL, HDL, triglycerides) and HOMA-IR pre- and post-operatively.
- Statistical analysis using Pearson's correlation for excess weight loss (EWL) and ANOVA for time-point differences.
Main Results:
- Significant reductions in total cholesterol, LDL cholesterol, triglycerides, and HOMA-IR post-LRYGBP (P < 0.0005).
- Significant increase in HDL cholesterol post-LRYGBP (P < 0.0005).
- Strong correlations found between lipid sub-fractions and EWL (P < 0.0005), with a more pronounced effect in male patients.
Conclusions:
- LRYGBP effectively improves lipid profiles and reduces insulin resistance in obese patients.
- Weight loss achieved through LRYGBP positively impacts cardiovascular risk factors.
- Male patients demonstrated a more significant improvement in lipid profiles compared to female patients.
More Related Videos
Related Concept Videos
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:06Lipid Digestion
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
01:25Lipid Catabolism
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...